Fig. 3
From: Impact of frontline treatment approach on outcomes of myeloid blast phase CML

Outcomes stratified by TKI received for patients treated with combination therapy plus a TKI for (a) event-free survival and (b) overall survival
From: Impact of frontline treatment approach on outcomes of myeloid blast phase CML

Outcomes stratified by TKI received for patients treated with combination therapy plus a TKI for (a) event-free survival and (b) overall survival